Simultaneous High-Resolution Whole-Brain MR Spectroscopy and [18F]FDG PET for Temporal Lobe Epilepsy.

Hui Huang,Miao Zhang,Yibo Zhao,Yudu Li,Wen Jin,Rong Guo,Wei Liu,Bingyang Cai,Jiwei Li,Siyu Yuan,Xinyun Huang,Xiaozhu Lin,Zhi-Pei Liang,Biao Li,Jie Luo
DOI: https://doi.org/10.1007/s00259-023-06465-0
2024-01-01
Abstract:Precise lateralizing the epileptogenic zone in patients with drug-resistant mesial temporal lobe epilepsy (mTLE) remains challenging, particularly when routine MRI scans are inconclusive (MRI-negative). This study aimed to investigate the synergy of fast, high-resolution, whole-brain MRSI in conjunction with simultaneous [18F]FDG PET for the lateralization of mTLE. Forty-eight drug-resistant mTLE patients (M/F 31/17, age 12–58) underwent MRSI and [18F]FDG PET on a hybrid PET/MR scanner. Lateralization of mTLE was evaluated by visual inspection and statistical classifiers of metabolic mappings against routine MRI. Additionally, this study explored how disease status influences the associations between altered N-acetyl aspartate (NAA) and FDG uptake using hierarchical moderated multiple regression. The high-resolution whole-brain MRSI data offers metabolite maps at comparable resolution to [18F]FDG PET. Visual examinations of combined MRSI and [18F]FDG PET showed an mTLE lateralization accuracy rate of 91.7
What problem does this paper attempt to address?